Analyst Review Alert: Agios Pharmaceuticals Inc (NASDAQ:AGIO)

The shares of Agios Pharmaceuticals Inc (NASDAQ:AGIO) currently has mean rating of 2.25 while 1 analysts have recommended the shares as “BUY”, 4 recommended as “OUTPERFORM” and 3 recommended as “HOLD”. The rating score is on a scale of 1 to 5 where 1 stands for strong buy and 5 stands for sell.

The company’s mean estimate for sales for the current quarter ending Jun-16 is 39.62 million by 8 analysts. The means estimate of sales for the year ending Dec-16 is 119.80 million by 8 analysts.

The mean price target for the shares of Agios Pharmaceuticals Inc (NASDAQ:AGIO) is at 62.83 while the highest price target suggested by the analysts is 90.00 and low price target is 46.00. The mean price target is calculated keeping in view the consensus of 9 brokerage firms.

The average estimate of EPS for the current fiscal quarter for Agios Pharmaceuticals Inc (NASDAQ:AGIO) stands at -0.48 while the EPS for the current year is fixed at -3.31 by 8 analysts.

The next one year’s EPS estimate is set at -4.93 by 8 analysts while a year ago the analysts suggested the company’s EPS at -3.31.

In its latest quarter ended on 31st March 2016, Agios Pharmaceuticals Inc (NASDAQ:AGIO) reported earnings of -$0.61. The posted earnings topped the analyst’s consensus by $0.18 with the surprise factor of 22.80%. In the matter of earnings surprises, the term “Cockroach Effect” is often implied. Cockroach Effect is a market theory that suggests that when a company reveals bad news to the public, there may be many more related negative events that have yet to be revealed. In the case of earnings surprises, if a company is suggesting a negative earnings surprise it means there are more to come.

On June 11, 2016 Agios Pharmaceuticals Inc (AGIO) announced initial data demonstrating that AG-348 achieved proof-of-concept in an ongoing Phase 2 study (DRIVE-PK) of patients with pyruvate kinase (PK) deficiency, a rare, potentially debilitating, congenital anemia. AG-348 is a novel, first-in-class, oral activator of both wild-type (normal) and mutated pyruvate kinase-R (PKR) enzymes. AG-348 is wholly owned by Agios. Data will be presented today at the 21st Congress of the European Hematology Association (EHA) taking place June 9-12, 2016 in Copenhagen.

DRIVE-PK is the first study to evaluate the safety and efficacy of AG-348 in patients with PK deficiency. As of the March 27, 2016 data cut-off, 18 transfusion-independent patients (13 with at least one missense mutation and five with two non-missense mutations) were treated with twice-daily dosing of AG-348 for up to six months. Treatment resulted in rapid and sustained hemoglobin increases of >1.0 g/dL in nine out of 18 patients (nine of 13 patients with at least one missense mutation), ranging from 2.3–4.9 g/dL with a mean maximum hemoglobin increase of 3.4 g/dL. It is estimated that approximately 80 percent of all PK deficiency patients carry at least one missense mutation. These data support the hypothesis that AG-348 restores metabolic function and has the potential to correct the underlying defect in the red blood cells of patients with PK deficiency.

“People with PK deficiency suffer from chronic anemia and a range of other complications brought on by both their disease and existing supportive therapies, including blood transfusions and splenectomy,” said Rachael Grace, M.D., of the Dana-Farber Boston Children’s Cancer and Blood Disorder Center and a principal investigator for the study. “These data are exciting for the hematology community and patients, as they demonstrate the potential for AG-348 to provide the first disease-modifying treatment with impressive and prolonged increases in hemoglobin levels.”

“These data have established proof-of-concept for AG-348, validating our novel approach to the treatment of rare genetic metabolic disorders by correcting the underlying enzymatic defect with a small molecule,” said Chris Bowden, M.D., chief medical officer at Agios. “The rapid and sustained hemoglobin increases and well-tolerated safety profile shown in this trial to date support continued study and moving into late-stage development. In addition, these data demonstrate the important potential role that PK activation may have in transforming treatment of PK deficiency.”

Analyst’s Ratings on: EPAM Systems Inc (NYSE:EPAM)

The shares of EPAM Systems Inc (NYSE:EPAM) currently has mean rating of 1.83 while 7 analysts have recommended the shares as “BUY”, 7 recommended as “OUTPERFORM” and 4 recommended as “HOLD”. The rating score is on a scale of 1 to 5 where 1 stands for strong buy and 5 stands for sell.

The company’s mean estimate for sales for the current quarter ending Jun-16 is 280.08 million by 11 analysts. The means estimate of sales for the year ending Dec-16 is 1.16 billion by 14 analysts.

The mean price target for the shares of EPAM Systems Inc (NYSE:EPAM) is at 83.76 while the highest price target suggested by the analysts is 100.00 and low price target is 70.00. The mean price target is calculated keeping in view the consensus of 16 brokerage firms.

The average estimate of EPS for the current fiscal quarter for EPAM Systems Inc (NYSE:EPAM) stands at 0.73 while the EPS for the current year is fixed at 3.07 by 15 analysts.

The next one year’s EPS estimate is set at 3.68 by 17 analysts while a year ago the analysts suggested the company’s EPS at 3.07. The analysts also projected the company’s long-term growth at 20.00% for the upcoming five years.

In its latest quarter ended on 31st March 2016, EPAM Systems Inc (NYSE:EPAM) reported earnings of $0.72. In the matter of earnings surprises, the term “Cockroach Effect” is often implied. Cockroach Effect is a market theory that suggests that when a company reveals bad news to the public, there may be many more related negative events that have yet to be revealed. In the case of earnings surprises, if a company is suggesting a negative earnings surprise it means there are more to come.

On June 23, 2016 EPAM Systems Inc (EPAM) has been ranked sixth in The Top 100 Digital Agencies Report, published by Econsultancy. The Top 100 Digital Agencies Report is an annual listing of the UK’s largest digital marketing, design and build, technical and creative agencies ranked by fee income from digital activities. With multiple delivery centers in Europe and a focused digital team in the UK, EPAM’s fast-growing digital engagement practice is a key area of growth for the company.

“Digital technology has fundamentally changed the way our clients engage customers and the marketplace. By combining over 20 years of product development and software engineering experience with our continually evolving suite of business strategy, innovation consulting, service and experience design, as well as IoT and advanced technology services, we are enabling our clients to fend off challengers and become the next generation of business disrupters,” said Kevin Labick, Co-Head of Digital Engagement, EPAM. “We’re excited to be recognized as a Top 100 Digital Agency in the UK and leader in our industry.”

What analysts have to say about Western Asset Mortgage Capital Corp (NYSE:WMC)?

The shares of Western Asset Mortgage Capital Corp (NYSE:WMC) currently has mean rating of 3.17 while 1 analysts have recommended the shares as “BUY”, Zero recommended as “OUTPERFORM” and 3 recommended as “HOLD”. The rating score is on a scale of 1 to 5 where 1 stands for strong buy and 5 stands for sell.

The company’s mean estimate for sales for the current quarter ending Dec-14 is 33.92 million by 4 analysts. The means estimate of sales for the year ending Dec-16 is 126.85 million by 4 analysts.

The mean price target for the shares of Western Asset Mortgage Capital Corp (NYSE:WMC) is at 9.15 while the highest price target suggested by the analysts is 10.00 and low price target is 8.00. The mean price target is calculated keeping in view the consensus of 5 brokerage firms.

The analysts also projected the company’s long-term growth at -28.90% for the upcoming five years.

In its latest quarter ended on 30th September 2016, Western Asset Mortgage Capital Corp (NYSE:WMC) reported earnings of $0.67. The posted earnings missed the analyst’s consensus by -$0.04 with the surprise factor of -5.60%. In the matter of earnings surprises, the term “Cockroach Effect” is often implied. Cockroach Effect is a market theory that suggests that when a company reveals bad news to the public, there may be many more related negative events that have yet to be revealed. In the case of earnings surprises, if a company is suggesting a negative earnings surprise it means there are more to come.

On June 23, 2016 Western Asset Mortgage Capital Corp (WMC) announced that its Board of Directors has declared a cash dividend of $0.31 per share for the second quarter of 2016. Today’s dividend is payable on July 26, 2016 to common shareholders of record as of July 5, 2016, with an ex-dividend date of June 30, 2016.

In addition, the Company estimates that its book value per share, as of May 31, 2016, was approximately $11.19.  The May 31, 2016 estimated book value is unaudited which has not been verified or reviewed by any third party and is subject to normal quarterly reconciliation and other procedures.  Further, the estimated book value is as of May 31, 2016 and does not include the dividend announced today.  Book value will fluctuate with market conditions, the results of the Company’s operations and other factors.  The Company’s current book value may be materially different from the May 31, 2016 estimated book value.

Stock Grabbing Investor’s Attention: Memorial Production Partners LP (NASDAQ:MEMP)

The shares of Memorial Production Partners LP (NASDAQ:MEMP) currently has mean rating of 3.27 while 1 analysts have recommended the shares as “BUY”, Zero recommended as “OUTPERFORM” and 6 recommended as “HOLD”. The rating score is on a scale of 1 to 5 where 1 stands for strong buy and 5 stands for sell.

The company’s mean estimate for sales for the current quarter ending Jun-16 is 124.12 million by 7 analysts. The means estimate of sales for the year ending Dec-16 is 430.33 million by 6 analysts.

The mean price target for the shares of Memorial Production Partners LP (NASDAQ:MEMP) is at 2.50 while the highest price target suggested by the analysts is 5.00 and low price target is 1.00. The mean price target is calculated keeping in view the consensus of 7 brokerage firms.

The average estimate of EPS for the current fiscal quarter for Memorial Production Partners LP (NASDAQ:MEMP) stands at -0.01 while the EPS for the current year is fixed at -0.29 by 6 analysts.

The next one year’s EPS estimate is set at -0.36 by 9 analysts while a year ago the analysts suggested the company’s EPS at -0.29. The analysts also projected the company’s long-term growth at -68.20% for the upcoming five years.

In its latest quarter ended on 31st March 2016, Memorial Production Partners LP (NASDAQ:MEMP) reported earnings of -$0.46. The posted earnings topped/missed the analyst’s consensus by -$0.43 with the surprise factor of -1433.30%. In the matter of earnings surprises, the term “Cockroach Effect” is often implied. Cockroach Effect is a market theory that suggests that when a company reveals bad news to the public, there may be many more related negative events that have yet to be revealed. In the case of earnings surprises, if a company is suggesting a negative earnings surprise it means there are more to come.

On June 20, 2016 Memorial Production Partners LP (MEMP) announced that it closed a transaction to sell certain assets located in the Permian Basin for cash consideration of approximately $37.4 million, subject to customary post-closing adjustments.  In addition, MEMP also announced today that it entered into a definitive agreement to sell certain of its non-core Rockies assets in Colorado and Wyoming for cash consideration of approximately $19.1 million, subject to customary purchase price adjustments.  The Rockies transaction is expected to close during the third quarter 2016 with an effective date of April 1, 2016.  Proceeds from the transactions will be used to reduce borrowings under MEMP’s revolving credit facility.

“Driving down costs, generating positive free cash flow and managing MEMP’s balance sheet is our key focus this year,” said John A. Weinzierl, Chairman and Chief Executive Officer.  “The divestiture of non-core properties in the Permian and Rockies is in line with our expectations and consistent with our strategy for 2016.  We also expect that the divestiture will enhance cash flow, improve operating efficiencies and better focus the partnership on our remaining core areas.”

The Permian Basin properties consisted of 285 gross (238 net) producing wells and produced approximately 1.2 MBoe/d during the first three months of 2016.  As of December 31, 2015, these assets contained estimated proved reserves of 3.1 MMBoe, or approximately 1% of the Partnership’s total estimated proved reserves of 1,268 Bcfe.

The Rockies properties consisted of 606 gross (188 net) producing wells and produced approximately 10.0 MMcfe/d during the first three months of 2016.  As of December 31, 2015, these assets contained estimated proved reserves of 25.5 Bcfe, or approximately 2% of the Partnership’s total estimated proved reserves of 1,268 Bcfe.

Analyst Activity: Limelight Networks, Inc. (NASDAQ:LLNW)

The shares of Limelight Networks, Inc. (NASDAQ:LLNW) currently has mean rating of 2.33 while 1 analysts have recommended the shares as “BUY”, 3 recommended as “OUTPERFORM” and 1 recommended as “HOLD”. The rating score is on a scale of 1 to 5 where 1 stands for strong buy and 5 stands for sell.

The company’s mean estimate for sales for the current quarter ending Jun-16 is 43.84 million by 6 analysts. The means estimate of sales for the year ending Dec-16 is 182.08 million by 6 analysts.

The mean price target for the shares of Limelight Networks, Inc. (NASDAQ:LLNW) is at 2.99 while the highest price target suggested by the analysts is 3.75 and low price target is 1.50. The mean price target is calculated keeping in view the consensus of 5 brokerage firms.

The average estimate of EPS for the current fiscal quarter for Limelight Networks, Inc. (NASDAQ:LLNW) stands at -0.01 while the EPS for the current year is fixed at -0.01 by 6 analysts.

The next one year’s EPS estimate is set at 0.05 by 6 analysts while a year ago the analysts suggested the company’s EPS at -0.01. The analysts also projected the company’s long-term growth at 2.00% for the upcoming five years.

In its latest quarter ended on 31st March 2016, Limelight Networks, Inc. (NASDAQ:LLNW) reported earnings of -$0.01. In the matter of earnings surprises, the term “Cockroach Effect” is often implied. Cockroach Effect is a market theory that suggests that when a company reveals bad news to the public, there may be many more related negative events that have yet to be revealed. In the case of earnings surprises, if a company is suggesting a negative earnings surprise it means there are more to come.

On June 23, 2016 Limelight Networks, Inc. (LLNW) will report financial results for the second quarter 2016 on Wednesday, July 27, 2016 at 4:00 p.m. EDT (1:00 p.m. PDT).

Management will host a quarterly conference call for investors at 4:30 p.m. EDT (1:30 p.m. PDT). Investors can access this call toll-free at (877) 388-8480 within the United States or +1 (678) 809-1592 outside of the United States.

The conference call will also be audiocast live from www.limelight.com and a replay will be available following the call from the Company’s website.

About Limelight

Limelight Networks (LLNW), a global leader in digital content delivery, empowers customers to better engage online audiences by enabling them to securely manage and globally deliver digital content, on any device. The company’s award winning Limelight Orchestrate™ platform includes an integrated suite of content delivery technology and services that helps organizations secure digital content, deliver exceptional multi-screen experiences, improve brand awareness, drive revenue, and enhance customer relationships — all while reducing costs. For more information, please visit www.limelight.com, read our blog, follow us on Twitter, Facebook and LinkedIn and be sure to visit Limelight Connect.

Stocks in Review: EnteroMedics Inc. (ETRM), Citigroup Inc. (C), Sirius XM Holdings Inc. (SIRI)

EnteroMedics Inc. (ETRM) traded within a range of $0.0475 to $0.056 after opening the day at $0.05. The company has seen its stock decrease in value by -97.46% so far this year. The stock was down close to -0.8% on active volume in last trading session and closed at $0.05 per share. After the recent fall, the stock is currently holding -98.16% below its 52 week high of $2.697 and 19.52% above its 12-month low of $0.0415. The shares are down by over -63.93% in the last three months, and the RSI indicator value of 39.96 is neither bullish nor bearish, tempting investors to stay on the sidelines.

EnteroMedics Inc., a medical device company, focuses on the design and development of devices that use neuroblocking technology to treat obesity, metabolic diseases, and other gastrointestinal disorders. Its proprietary neuroblocking technology is designed to intermittently block the vagus nerve using electrical impulses. The company develops the Maestro Rechargeable System, which is used to limit the expansion of the stomach, control hunger sensations between meals, reduce the frequency and intensity of stomach contractions, and produce a feeling of early and prolonged fullness. It has collaboration with Mayo Clinic for the development and testing of products for the treatment of obesity. The company was formerly known as Beta Medical, Inc. and changed its name to EnteroMedics Inc. in 2003. EnteroMedics Inc. was founded in 2002 and is headquartered in St. Paul, Minnesota.

Citigroup Inc. (C) failed to extend gains with the stock declining -0.08% or $-0.05 to close the day at $60.75 on light trading volume of 15.08M shares, compared to its three month average trading volume of 21.72M. The New York New York 10013 based company has been outperforming the money center banks group over the past 52 weeks, with the stock gaining 17.89%, compared to the industry which has dropped -6.16% over the same period. With RSI of 71.12, the stock should still continue to rise and get closer to its one year target estimate of $61.09, making it a hold for now.

Citigroup Inc., a diversified financial services holding company, provides various financial products and services for consumers, corporations, governments, and institutions worldwide. It operates through two segments, Citicorp and Citi Holdings. The Citicorp segment offers traditional banking services to retail customers through retail banking, commercial banking, Citi-branded cards, and Citi retail services. This segment also provides various banking, credit card lending, and investment services through a network of local branches, offices, and electronic delivery systems. In addition, it offers wholesale banking products and services to corporate, institutional, public sector, and high-net-worth clients. Further, this segment provides fixed income and equity sales and trading, foreign exchange, prime brokerage, derivative services, equity and fixed income research, corporate lending, investment banking and advisory services, private banking, cash management, trade finance, and securities services. As of December 31, 2015, it operated 2,994 branches in 24 countries. The Citi Holdings segment provides consumer loans; portfolio of securities, loans, and other assets; and retail alternative investment and other services. Citigroup Inc. was founded in 1812 and is based in New York, New York.

Sirius XM Holdings Inc. (SIRI) dropped $0 to close the day at a new closing price of $4.53, a 0% decrease in value from its previous closing price that moved the stock 38.02% above its 52 week low of $3.29. A total of 15.02M shares exchanged hands during the day compared with its three month average trading volume of 41.6M. The stock, which fluctuated between $4.52 and $4.57 during the day, currently situated -2.58% below its 52 week high. The stock is down by -0.88% in the past one month and up by 7.86% over the past three months. With a one year target estimate of $4.89 and RSI of 55.44, the stock still has upside potential, making it a hold for now.

Sirius XM Holdings Inc. provides satellite radio services in the United States. The company broadcasts music plus sports, entertainment, comedy, talk, news, traffic, and weather programs, including various music genres ranging from rock, pop and hip-hop to country, dance, jazz, Latin, and classical; live play-by-play sports from principal leagues and colleges; multitude of talk and entertainment channels for various audiences; national, international, and financial news; and local traffic and weather reports for 21 metropolitan markets. It also streams music and non-music channels over the Internet; and offer applications to allow consumers to access its Internet radio service on smartphones and tablet computers. In addition, the company distributes satellite radios through the sale and lease of new vehicles; and acquires subscribers through the sale and lease of previously owned vehicles with factory-installed satellite radios. Its satellite radio systems include satellites, terrestrial repeaters, and other satellite facilities; studios; and radios. Further, the company provides satellite television services, which offer music channels on the DISH NETWORK satellite television service as a programming package; Travel Link, a suite of data services that include graphical weather, fuel prices, sports schedule and scores, and movie listings; real-time traffic services; and real-time weather services. Additionally, it offers location-based services through two-way wireless connectivity, including safety, security, convenience, maintenance and data services, remote vehicles diagnostics, stolen or parked vehicle locator services, and monitoring of vehicle emission systems. The company also sells satellite and Internet radios directly to consumers through its Website, as well as through national and regional retailers. The company was founded in 1990 and is headquartered in New York, New York. Sirius XM Holdings Inc. operates as a subsidiary of Liberty Media Corporation.